Yang Rohr supports HB4203 to broaden insurance for cancer screening coverage

Rep. Janet Yang Rohr (D-41st) cast her vote in favor of HB4203, legislation designed to extend insurance coverage for cancer screenings, during the 104th General Assembly on May 31, 2026, according to the Illinois House. The measure cleared the House with unanimous support in a 115-0 vote.

The official summary refers to the bill as: "INS CD-CANCER SCREENINGS."

The following summary clarifies the actual bill language and may reflect some explanation or interpretation for clarity.

HB4203 modifies the Illinois Insurance Code to include expanded coverage for specific cancer screenings. The bill designates individuals with elevated CA-125 blood test results as "at risk for ovarian cancer." It calls for annual coverage, without cost-sharing, for cervical smear or Pap tests, annual prostate cancer screenings for designated groups, and ovarian cancer surveillance through a range of approved methods, such as ultrasounds, MRIs, x-rays, CT scans, and CA-125 blood tests. Certain limited coverage and high-deductible plans linked to health savings accounts are exempt. The new requirements will take effect Jan. 1, 2028.

The record for HB4203 lists 'Senate Floor Amendment No. 1 House Concurs' as the most recent action.

Rohr earned her bachelor's degree from Northwestern University in 2002 and received her MBA from the University of Chicago Booth School of Business in 2010.

A member of the Democratic Party, Rohr was first elected to the Illinois House in 2021 to represent the 41st District, succeeding Grant Wehrli.

In Illinois, bills move through a multi-step legislative process that includes introduction in either chamber, committee scrutiny, floor debates, and approval votes in both the House and Senate, before proceeding to the governor for final approval or veto. The General Assembly follows a biennial schedule, and although thousands of proposals are filed each session, only a small percentage successfully become law.